Skip to main content
My Experience
Login Required
Program
Full Program
Browse By Date
Friday, April 22, 2022
Saturday, April 23, 2022
Sunday, April 24, 2022
Browse By Title
Browse By Presenter
CME Program
Non-CME Industry Sessions
Abstracts and ePosters
Browse by Track
Browse by Presenter
Sponsors
Login Required
Attendees
Login Required
CME and Evaluation Information
Login Required
Meeting Info and FAQ
My User Profile
Login Required
Kidney Cancer Association Info
Upcoming IKCS Meetings
Toggle navigation
Login
Search
Home
My Experience
Login Required
Program
Full Program
Browse By Date
Friday, April 22, 2022
Saturday, April 23, 2022
Sunday, April 24, 2022
Browse By Title
Browse By Presenter
CME Program
Non-CME Industry Sessions
Abstracts and ePosters
Browse by Track
Browse by Presenter
Sponsors
Login Required
Attendees
Login Required
CME and Evaluation Information
Login Required
Meeting Info and FAQ
My User Profile
Login Required
Kidney Cancer Association Info
Upcoming IKCS Meetings
Tweets by 2022 IKCS: Europe
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
4 results found
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
G
Gauthier, Kelsey
Arcus Biosciences
21
:
AB521 is a Novel and Potent Clinical-stage HIF-2α Inhibitor for the Treatment of Renal Cell Carcinoma
Kelsey Gauthier
Favorite
Geertsen, Louise
Department of Urology, Odense University Hospital, Denmark
26
:
Circulating tumor DNA in patients with renal cell carcinoma. A systematic review of the literature
Louise Geertsen
Favorite
Goebell, Peter
Urologische und Kinderurologische Universitätsklinik, Erlangen
16
:
Sequential treatment patterns over time for advanced renal cell carcinoma: data from the German research platform CARAT
Peter Goebell
Favorite
Grünwald, Viktor
University-Hospital Essen
14
:
Real-World Clinical Outcomes of tivozanib as first-line treatment of metastatic renal cell carcinoma in Germany
Viktor Grünwald
Favorite
Back to Top
